AZD6422

· AstraZeneca

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AZD6422, covering 2025-07-31 to 2025-07-31. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Trial of AZD6422 in CLDN18.2+ GI Tumors [Phase 1]